2. Cyrus S, Burkardt D, Weaver DD, Gibson WT. 2019; PRC2-complex related dysfunction in overgrowth syndromes: a review of
EZH2,
EED, and
SUZ12 and their syndromic phenotypes. Am J Med Genet C Semin Med Genet. 181:519–31. DOI:
10.1002/ajmg.c.31754. PMID:
31724824.
3. Suri T, Dixit A. 2017; The phenotype of
EZH2 haploinsufficiency-1.2-Mb deletion at 7q36.1 in a child with tall stature and intellectual disability. Am J Med Genet A. 173:2731–5. DOI:
10.1002/ajmg.a.38356. PMID:
28696078.
4. Imagawa E, Albuquerque EVA, Isidor B, Mitsuhashi S, Mizuguchi T, Miyatake S, et al. 2018; Novel
SUZ12 mutations in Weaver-like syndrome. Clin Genet. 94:461–6. DOI:
10.1111/cge.13415. PMID:
30019515.
5. Imagawa E, Higashimoto K, Sakai Y, Numakura C, Okamoto N, Matsunaga S, et al. 2017; Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome. Hum Mutat. 38:637–48. DOI:
10.1002/humu.23200. PMID:
28229514.
Article
6. Cyrus SS, Cohen ASA, Agbahovbe R, Avela K, Yeung KS, Chung BHY, et al. 2019; Rare
SUZ12 variants commonly cause an overgrowth phenotype. Am J Med Genet C Semin Med Genet. 181:532–47. DOI:
10.1002/ajmg.c.31748. PMID:
31736240.
8. Kehrer-Sawatzki H, Wahlländer U, Cooper DN, Mautner VF. 2021; Atypical
NF1 microdeletions: challenges and opportunities for genotype/phenotype correlations in patients with large
NF1 deletions. Genes (Basel). 12:1639. DOI:
10.3390/genes12101639. PMID:
34681033. PMCID:
PMC8535936.
Article
9. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, et al. 2010;
NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 31:E1506–18. DOI:
10.1002/humu.21271. PMID:
20513137.